Jake Van Naarden

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

LLY

Current role

CEO

4 calls Latest call 2026-08-05

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	ELI LILLY & Co (LLY)	Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development	$920,192	—	$4,500,000	—	$2,006,019	$72,519	$7,586,097
2024	ELI LILLY & Co (LLY)	Executive Vice President and President, Loxo@Lilly	$890,385	—	$2,700,248	—	$2,003,366	$113,062	$5,773,948
2023	ELI LILLY & Co (LLY)	Executive Vice President and President, Loxo@Lilly	$830,769	—	$2,424,200	—	$1,503,692	$49,846	$4,886,520
2022	ELI LILLY & Co (LLY)	Executive Vice President and President, Loxo@Lilly	$735,577	—	$1,933,250	—	$882,692	$44,135	$3,621,832
2021	ELI LILLY & Co (LLY)	Executive Vice President and President, Loxo@Lilly	$745,649	$218,715	$4,099,500	—	$1,029,507	$12,462	$6,122,742

Earnings-call appearances and filed executive appointments or departures, newest first.